Detalles de la búsqueda
1.
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial.
JAMA
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38820549
2.
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study.
BMC Med
; 21(1): 173, 2023 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147645
3.
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study.
Ther Adv Med Oncol
; 16: 17588359241260985, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38882443
4.
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Nat Med
; 30(1): 249-256, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191615
5.
Depiction of neuroendocrine features associated with immunotherapy response using a novel one-class predictor in lung adenocarcinoma.
Discov Oncol
; 14(1): 71, 2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199872
6.
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Lung Cancer
; 180: 107194, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163774
7.
Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study.
Front Immunol
; 13: 1002938, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275698
8.
The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study.
Front Med (Lausanne)
; 9: 918468, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267618
9.
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.
J Clin Oncol
; 40(26): 3065-3076, 2022 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442766
10.
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study.
Cancer Commun (Lond)
; 42(1): 3-16, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699693
11.
Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study.
J Thorac Oncol
; 17(10): 1192-1204, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35724798
12.
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study.
J Thorac Oncol
; 17(11): 1306-1317, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049654
13.
Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
Cancer Immunol Immunother
; 60(5): 715-30, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21331814
14.
Retracted: Long non-coding RNA TP73-AS1 facilitates progression and radioresistance in lung cancer cells by the miR-216a-5p/CUL4B axis with exosome involvement.
Thorac Cancer
; 12(3): 409, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32841514
15.
Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma.
Theranostics
; 11(1): 257-267, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33391473
16.
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.
Cancer Commun (Lond)
; 41(9): 889-903, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184418
17.
Combined perioperative EOX chemotherapy and postoperative chemoradiotherapy for locally advanced gastric cancer.
Mol Clin Oncol
; 7(2): 211-216, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28781787
18.
[Combined chemotherapy with domestic gemcitabine plus carboplatin in the treatment of advanced non-small cell lung cancer].
Zhongguo Fei Ai Za Zhi
; 9(1): 82-3, 2006 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-21144290
19.
MicroRNA-130a regulates cell malignancy by targeting RECK in chronic myeloid leukemia.
Am J Transl Res
; 8(2): 955-67, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27158382
20.
The relationship among human papilloma virus infection, survivin, and p53 gene in lung squamous carcinoma tissue.
Saudi Med J
; 31(12): 1331-6, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135996